Stoneridge Investment Partners Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
PNC Financial Services
PNC
|
+$2.97M |
| 2 |
Becton Dickinson
BDX
|
+$2.9M |
| 3 |
Humana
HUM
|
+$2.71M |
| 4 |
Ross Stores
ROST
|
+$2.4M |
| 5 |
Assurant
AIZ
|
+$1.83M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$10.8M |
| 2 |
Apple
AAPL
|
+$9.54M |
| 3 |
CVS Health
CVS
|
+$9.32M |
| 4 |
NVIDIA
NVDA
|
+$8.97M |
| 5 |
Chubb
CB
|
+$7.65M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32.77% |
| 2 | Financials | 12.97% |
| 3 | Healthcare | 10.55% |
| 4 | Industrials | 9.02% |
| 5 | Consumer Discretionary | 8.96% |
Similar funds
Stoneridge Investment Partners's Q1 2025 Portfolio in Review
As of Q1 2025, Stoneridge Investment Partners held 162 positions worth $118M, down 58% from $280M the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Stoneridge Investment Partners withdrew a net $150M in Q1 2025, closing 47 positions and reducing 50 holdings. Its most notable exit was CVS Health, an estimated $9.32M position sold in full.
By sector, the portfolio is most concentrated in Technology at 33% of assets, down from 37% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Stoneridge Investment Partners opened a new position in Becton Dickinson worth $2.86M.
- Stoneridge Investment Partners's largest Q1 2025 buy was Becton Dickinson: 12,485 shares worth $2.86M.
- Stoneridge Investment Partners added most to PNC Financial Services in Q1 2025, an estimated $2.97M increase.
- Stoneridge Investment Partners's biggest Q1 2025 reduction was Microsoft, cutting an estimated $10.8M.
- Stoneridge Investment Partners fully exited CVS Health in Q1 2025, selling an estimated $9.32M.
- Stoneridge Investment Partners's ten largest holdings make up 37% of its $118M portfolio in Q1 2025.
- Stoneridge Investment Partners opened 27 new positions and closed 47 in Q1 2025.
- Stoneridge Investment Partners's portfolio value fell 58% quarter-over-quarter to $118M.
Based on Stoneridge Investment Partners's 13F filing for Q1 2025, filed 14 May 2025.